Americans pay nearly 3x as much as patients in other wealthy countries for the same prescription drugs.

The impact: Nearly 40% of Americans report cutting pills, skipping doses or not filling prescriptions because of high prescription drug prices.

A proposed bipartisan pricing policy aims to narrow that gap.

• Most Favored Nation drug pricing would align U.S. medication prices with the lowest prices drugmakers offer in comparable wealthy countries.
• President Trump issued an executive order pursuing the approach in 2025.
• Bipartisan bill H.R. 3493 would codify Most Favored Nation drug pricing into law, making the policy permanent.

Learn more on what could change for Americans at the pharmacy counter.